SUPERNUS PHARMACEUTICALS, INC.

Nasdaq:SUPN

Pharmaceutical Preparations·ROCKVILLE, MD

CEO

Khattar Jack A.

CFO

Dec Timothy C

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/2/26	→
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/5/25	→
10-Q	Q1 2025	3/31/25	5/6/25	→
10-K	FY 2024	12/31/24	2/25/25	→
10-Q	Q3 2024	9/30/24	11/4/24	→
↓

Earnings Releases (8-K)

36 shown

Filed	Period
2/24/26	Q1 FY2026	→
2/12/26	Q1 FY2026	→
11/4/25	Q4 FY2025	→
10/21/25	Q3 FY2025	→
8/5/25	Q3 FY2025	→
7/22/25	Q2 FY2025	→
↓

News (8-K)

44 shown

Filed	Type	Description
2/24/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
1/28/26	Other	8-K Filing	→
10/16/25	Other	8-K Filing	→
8/4/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
7/31/25	Acquisition	Entry into a Material Definitive Agreement	→
6/17/25	Vote	Submission of Matters to a Vote of Security Holders	→
↓

Prospectuses & Registrations

12 shown

Filed	Form	Description
4/30/25	ARS	ARS	→
2/24/25	S-8 POS	FORM S-8 POS	→
6/17/24	S-8	S-8	→
4/29/24	ARS	ARS	→
5/1/23	ARS	ARS	→
6/25/21	S-8	S-8	→
↓

Filing History(1001 filings)

TypeDateAccessionPeriodSize

144

Mar 6, 2026

0001950047-26-002317

—

5.9 KB

144

Mar 5, 2026

0001950047-26-002236

—

4.6 KB

Mar 3, 2026

0001539937-26-000004FORM 4

Feb 28, 2026

5.4 KB

Mar 3, 2026

0001194020-26-000008FORM 4

Feb 28, 2026

7.3 KB

Mar 3, 2026

0001804567-26-000008FORM 4

Feb 28, 2026

5.4 KB

10-K

Mar 2, 2026

0001356576-26-00001110-K

Dec 31, 2025

13.7 MB

Feb 26, 2026

0001804567-26-000006FORM 4

Feb 25, 2026

8.3 KB

Feb 26, 2026

0001194020-26-000006FORM 4

Feb 25, 2026

8.3 KB

Feb 26, 2026

0001539215-26-000006FORM 4

Feb 25, 2026

8.4 KB

Feb 26, 2026

0001836067-26-000006FORM 4

Feb 25, 2026

8.4 KB

Feb 25, 2026

0001194020-26-000004FORM 4

Feb 24, 2026

18.0 KB

Feb 25, 2026

0001005544-26-000004FORM 4

Feb 24, 2026

6.7 KB

Feb 25, 2026

0001438462-26-000004FORM 4

Feb 24, 2026

6.7 KB

Feb 25, 2026

0001745316-26-000004FORM 4

Feb 24, 2026

6.8 KB

Feb 25, 2026

0001539215-26-000004FORM 4

Feb 24, 2026

18.0 KB

Feb 25, 2026

0001804567-26-000004FORM 4

Feb 24, 2026

18.0 KB

Feb 25, 2026

0001836067-26-000004FORM 4

Feb 24, 2026

18.1 KB

Feb 25, 2026

0001256088-26-000004FORM 4

Feb 23, 2026

10.0 KB

8-K

Feb 24, 2026

0001356576-26-0000078-K

Feb 24, 2026

149.8 KB

8-K

Feb 24, 2026

0001356576-26-0000048-K

Feb 24, 2026

414.1 KB

Feb 23, 2026

0001899935-26-000005FORM 4

Feb 19, 2026

10.7 KB

Feb 20, 2026

0001194020-26-000002FORM 4

Feb 18, 2026

8.3 KB

Feb 20, 2026

0001539215-26-000002FORM 4

Feb 18, 2026

8.3 KB

Feb 20, 2026

0001836067-26-000002FORM 4

Feb 18, 2026

8.4 KB

Feb 20, 2026

0001804567-26-000002FORM 4

Feb 18, 2026

8.3 KB

25 filings shown

SUPERNUS PHARMACEUTICALS, INC.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1001 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
4/30/25	DEFA14A	DEFA14A	→
4/30/25	DEF 14A	DEF 14A	→
4/29/24	DEFA14A	DEFA14A	→
4/29/24	DEF 14A	DEF 14A	→
5/1/23	DEFA14A	DEFA14A	→
5/1/23	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
3/3/26	4	4	→
3/3/26	4	4	→
3/3/26	4	4	→
2/26/26	4	4	→
2/26/26	4	4	→
2/26/26	4	4	→
↓

Filed	Form	Description
3/6/26	144	144	→
3/5/26	144	144	→
2/19/26	144	144	→
2/18/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/2/26	SCHEDULE 13G	SCHEDULE 13G	→
↓